Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Treatment options like buprenorphine are rendered less effective by the prevalence of fentanyl, xylazine and other synthetic drugs.
At a suggested retail price of $44.99 per pack, affordability can be a barrier to access.
NIH study suggests brain’s salience network is important for understanding substance use disorders.
Offering hepatitis C treatment at the point of diagnosis streamlines care, saving both time and money.
Study findings suggest this circuitry might be targeted in potential therapies for a variety of substance use disorders.
Hepatitis C prevalence was higher among people with unstable housing and those who injected drugs every day.
Modern antivirals can cure 95% of people with HCV, lowering the risk of cirrhosis, liver cancer and liver failure.
The awards to states and local health departments marked Overdose Awareness Day on August 31.
NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care.
The CDC estimates that 21% of people living with HIV also have hepatitis C virus.
Hepatitis A and B declined in 2021, but new hepatitis C cases have doubled since 2014.
Drug-related mortality, including overdose, was the leading cause of death.
NASTAD’s Board Chair, Dave Kern, describes his Chair’s Challenge to NASTAD and health departments.
Eleven years ago, Truvada became the first medication approved for HIV prevention. Today, disparities in PrEP coverage still exist.
The COVID pandemic, workforce shortages, red tape and discrimination have slowed HIV response efforts.
Recent drug use along with unstable housing increased the risk of acquiring HCV again.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.